Société Immunovant, Inc. Nasdaq
Actions
US45258J2015
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Peter Salzmann
CEO | Chief Executive Officer | 56 | 01/06/19 |
Eva Barnett
DFI | Director of Finance/CFO | 44 | 04/10/21 |
Sheetal Patel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ian Gourley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Maria Alba
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jennifer Moseley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/20 |
Jay Stout
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/04/23 |
Chief Tech/Sci/R&D Officer | 66 | 01/06/21 | |
Chau Cheng
IRC | Investor Relations Contact | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 18/12/19 |
Andrew Fromkin
BRD | Director/Board Member | 58 | 18/12/19 |
Douglas Hughes
BRD | Director/Board Member | 62 | 18/12/19 |
Atul Pande
BRD | Director/Board Member | 69 | 18/12/19 |
Frank Torti
CHM | Chairman | 45 | 18/12/19 |
Eric Venker
BRD | Director/Board Member | 37 | 18/02/20 |
Peter Salzmann
CEO | Chief Executive Officer | 56 | 01/06/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 146 053 941 | 62 422 461 ( 42,74 %) | 0 | 42,74 % |
Coordonnées société
![Adresse Immunovant, Inc.](https://cdn.zonebourse.com/static/address/57878422.png)
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+21,85 % | 46,44 Md | |
+37,63 % | 39,1 Md | |
-8,05 % | 38,76 Md | |
+29,04 % | 31,24 Md | |
-13,75 % | 25,8 Md | |
+10,65 % | 25,9 Md | |
+38,43 % | 13,12 Md | |
-6,92 % | 11,32 Md | |
-12,29 % | 10,68 Md |